Kiora Pharmaceuticals (KPRX) Debt Ratio (2014 - 2023)

Kiora Pharmaceuticals (KPRX) has reported Debt Ratio for 6 consecutive years, with 0.03 the latest figure, recorded in Q3 2023.

• For the quarter ending Q3 2023, Debt Ratio rose 75.31% year-over-year to 0.03; the trailing twelve-month figure through Sep 2023 stood at 0.03 (up 75.31% YoY), and the FY2022 full-year result was 0.02, changed N/A from the prior year.
• Debt Ratio rose to 0.03 in Q3 2023 per KPRX's latest filing, from 0.02 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.03 in Q4 2020 and bottomed at 0.01 in Q1 2021.
• Historically, Debt Ratio has averaged 0.02 across 4 years, with a median of 0.02 in 2023.
• The widest YoY moves for Debt Ratio: up 75.31% in 2023, down 19.13% in 2023.
• Over 4 years, Debt Ratio stood at 0.03 in 2020, then tumbled by 57.9% to 0.01 in 2021, then climbed by 27.94% to 0.02 in 2022, then surged by 80.41% to 0.03 in 2023.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.03, 0.02, and 0.02 for Q3 2023, Q2 2023, and Q1 2023 respectively.